1. New Biogen data showed no major safety issues for its Alzheimer's drug — Lilly puts its oncology future in Lox’s hands — Sage Therapeutics depression drug fails phase 3 trial — See more on our front page news

    TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

Eli Lilly

Anonymous board for Eli Lilly.


Sort By:
Title
Replies Views
Last Message ↓
  1. anonymous
    Replies:
    10
    Views:
    650
  2. anonymous
    Replies:
    1
    Views:
    146
  3. anonymous
    Replies:
    7
    Views:
    1,686
  4. Anonymous
    Replies:
    89
    Views:
    45,409
  5. anonymous
    Replies:
    123
    Views:
    33,235
  6. anonymous
    Replies:
    12
    Views:
    1,129
  7. anonymous
    Replies:
    14
    Views:
    1,803
  8. anonymous
    Replies:
    109
    Views:
    14,730
  9. anonymous
    Replies:
    9
    Views:
    747
  10. anonymous
    Replies:
    311
    Views:
    84,877
  11. anonymous
    Replies:
    3
    Views:
    431
  12. anonymous
    Replies:
    17
    Views:
    3,113
  13. anonymous
    Replies:
    2
    Views:
    734
  14. anonymous
    Replies:
    55
    Views:
    7,067
  15. anonymous
    Replies:
    40
    Views:
    5,407
  16. anonymous
    Replies:
    18
    Views:
    1,846
  17. anonymous
    Replies:
    26
    Views:
    9,733
  18. anonymous
    Replies:
    42
    Views:
    23,877
  19. anonymous
    Replies:
    6
    Views:
    1,383
  20. anonymous
    Replies:
    10
    Views:
    2,319

Thread Display Options

Loading...